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Introduction and Background
On February 27th 2017, the World Health Organization 
(WHO) published a list of the top twelve resistant bacteria that 
greatly endanger human health (Press Association, 2017). Drug 
resistant and multi-drug resistant bacteria are one of the most 
serious public health threats the world faces today. Antibacterial 
resistance is the ability of bacteria to survive even in the pres-
ence of antibiotics. The development of antibiotics has made a 
??????? ???????????? ???????????????????????????????????????????
professionals to successfully combat many diseases. However, 
with the rise of the use of antibiotics, drug resistance has 
evolved, and according to WHO statistics, 700,000 people die 
annually from infections and diseases that have resulted from 
such resistant bacteria (Press Association, 2017).
Method
The research discussed in this paper was compiled from var-
ious published articles obtained from Touro’s online database 
including Proquest as well as PubMed’s database to research 
the actions of antibiotics, drug resistant bacteria, and the use of 
silver nanoparticles against drug resistant bacteria. 
A. Antibiotics and their mechanism of action
??????????????????????????????????????????????????????????????????
the growth of bacteria. Antibiotics are grouped into different 
classes based on their mechanism of action, and they can either 
disrupt the cell membrane, or they can inhibit cell wall synthesis, 
protein synthesis, DNA replication and repair, RNA synthesis, 
or various metabolic pathways.
1. Inhibition of Cell Wall Synthesis
Bacterial cell walls are comprised of peptidoglycan, the cytoplasmic 
membrane, and in gram negative bacteria, the outer membrane. 
The peptidoglycan, the strongest layer of the cell wall, is a netlike 
arrangement of glycan and peptide strands. The biosynthesis of 
the peptidoglycan is catalyzed by thirty different enzymes (Shah, 
2015). Transglycosylases and transpeptidases are two enzymes 
?????????? ????????????????????? ??????????????????????????????????
new peptidoglycan units to extend the sugar chain and by link-
ing the amides of the peptide strands, respectively (Walsh, 2000). 
Numerous antibiotics, like the B-lactam class of antibiotics, target 
different steps in the synthesis of the peptidoglycan. Penicillins 
and cephalosporins act as pseudo-substrates for the penicillin 
binding proteins (PBPs), the active site of the transpeptidases, in 
order to prevent the cross-linking of the PG.  The cross-linking 
action of the transpeptidases is responsible for the strength of 
????????????????????????????????????????????????????????????????????-
er and therefore more prone to lysis. When B-lactam antibiotics 
bind to the PBPs, the oxygen from the serine residue located near 
the PBP attacks the B-lactam ring and forms a penicilloyl-enzyme 
complex. The serine is then acylated by the b-lactam which thus 
inactivates transpeptidases (Walsh, 2000). Consequently, trans-
peptidases can no longer bind to the substrate, and therefore the 
enzyme cannot complete the cross linking action (Andersson, et. 
al. 2001) (Bockstael, Aerschot, 2009). 
Vancomycin is a drug that belongs to the glycopeptide class of 
antibiotics. Like the B-lactams, vancomycin targets the synthesis 
of the cell wall. However, rather than targeting the enzymes 
involved in the production of the PG, vancomycin targets the 
????????????????????????????????????????????????????????????
terminus of each uncross-linked peptidoglycan (Lange et. al. 
2007).  By blocking the substrate of both the transpeptidases 
and transglycosylases, vancomycin and other glycopeptides in-
hibit the cross linking of the peptidoglycan, resulting in a weaker 
cell wall that is subject to osmotic lysis (Walsh, 2000)
2. Disruption of the Cell Membrane
The cell membrane of bacterial cells are semipermeable mem-
branes that are comprised of phospholipids, carbohydrates, and 
proteins.  Antibiotics like polymyxins and lipopeptides have the 
ability to disrupt the bacterial cell membrane. Polymyxins like 
colistin are cationic cyclic peptides that bind to the phospholip-
ids in the bi-layer. By interacting with the negatively charged cell 
membrane (Taneja, Kaur, 2016), colistin disrupts the bacterial cell 
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tant bacteria. This paper attempts to investigate the antibacterial potential of silver nanoparticles against drug resistant bacteria. 
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bactericidal effects by adsorbing to the cell surface and by entering the cell.  The small size of the particles confers it with a high 
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membrane by displacing divalent ions, like calcium and magne-
sium, from the lipids present on surface of the cell. The disruption 
of the cell membrane causes cell leakage and ultimately cell death 
(Biswas, et. al, 2012) (Bockstael, Aerschot, 2009). Similarly, amino-
glycosides can also displace these divalent ions to increase the 
membrane’s permeability, resulting in the leakage of intracellular 
content and cell death (Lange, et. al. 2007).
Furthermore, daptomycin, a lipopeptide, can also disrupt the 
cell membrane. However, rather than displacing calcium and 
magnesium ions, daptomycin forms pores in the membrane by 
inserting its tail into the membrane. Consequently, there is a 
??????????????????????????????????????????????????????????????-
polarization occurs (Shah, 2015) (Bockstael, Aerschot, 2009). 
Besides for causing cell depolarization, daptomycin can also 
inhibit the production of lipoteichoic acid which is responsi-
ble for regulating both cell division and cell shape (Bockstael, 
Aerschot, 2009). 
3. Inhibition of Protein Synthesis
In addition to targeting the synthesis of the cell wall and cell 
membrane, other antibiotics exert their effects by inhibiting 
bacterial protein synthesis. Ribosomes are essential to the syn-
thesis of proteins as they translate the genes from mRNA into 
proteins through the three steps of initiation, elongation, and 
termination. The bacterial 70S ribosome has two subunits: the 
50s subunit and the 30s subunit. While the large 50s subunit 
contains a 5S rRNA, a 23S rRNA and 36 proteins, the small-
er 30S subunit is comprised of 16S rRNA and 21 proteins. 
Antibiotics can exert their effects by targeting either the 30S or 
the 50S subunit (Bockstael, Aerschot, 2009). 
Targeting the 30S Subunit
The 30S subunit contains the site where the codons are recog-
nized by their corresponding tRNA anticodons. Transfer RNAs 
help with the process of translation by acting at either the A site, 
the P site, or the E site (Lange, et. al. 2007). 
Aminoglycosides like gentamicin and tobramycin interact with 
the 16s RNA located in the 30S subunit. By hydrogen bonding 
with the substituents on the aminoglycoside cyclitol ring in the 
16s RNA located at the A site, mistranslation occurs, and as a 
result abnormal proteins are produced. These aberrant proteins 
are then incorporated into the bacterial cell wall, ultimately re-
sulting in a weak cell wall which is associated with cell leakage and 
further penetration of the drug into the cell (Lange, et. al. 2007) 
(Bockstael, Aerschot, 2009).
Tetracyclines bind to the 30s subunit (Lange, et. al. 2007) to 
prevent the elongation step of protein synthesis. By blocking the 
substrate of the incoming tRNAs, these antibiotics prevent new 
amino acids from being added to the growing amino acid chain 
(Shah, 2015). 
Targeting the 50S Subunit
While the antibiotics discussed above inhibit protein synthesis 
via the 30S subunit, many other drugs have the ability to affect 
protein synthesis through the 50S subunit. The 50S subunit is 
associated with peptidyl transferase activity as well as the for-
mation of peptide bonds (Bockstael, Aerschot, 2009).
Chloramphenicol, a broad spectrum antibiotic that is used 
against both gram positive and negative bacteria, binds to the 
23s RNA on the 50S subunit. This class of drugs inhibits the for-
mation of peptide bonds by preventing the tRNAs from binding 
to the A site (Bockstael, Aerschot, 2009). 
The antibiotic class of macrolides binds to the 23S rRNA. 
Consequently, the exit tunnel that helps transport the peptide 
away from the peptidyl transferase center is blocked. 
Lincosamides, like clindamycin, attack both the A site and P site 
located in the peptidyl-transferase center (Lange, et. al.2007). 
As a result, lincosamides inhibit the initiation of peptide chain 
synthesis and detach tRNAs from the ribosome (Bockstael, 
Aerschot, 2009). 
Streptogramins affect protein synthesis and the action of the 
peptidyl transferase center activity by binding to the 23S subunit 
on the 50S ribosome. There are two types of streptogramins, 
Type A and Type B. While type A prevents the step of elonga-
tion by blocking the substrate of the peptidyl-transferase center, 
type B stimulates the premature release of incomplete peptide 
bonds by inhibiting peptide bond synthesis (Bockstael, Aerschot, 
2009).
Oxazolidinones act by targeting the 50S subunit. The drug 
linezolid binds to the 23S subunit located on the 50S ribosome. 
By binding to this subunit, the formation of the complex be-
tween tRNA, mRNA, and the ribosome is blocked which thus 
????????????????????????????????????????????????????????????????
is already formed, oxazolidinones can exert their effects by pre-
venting the translocation of the peptidyl RNA from the A site to 
the P site (Bockstael, Aerschot, 2009).
4. Inhibition of Metabolic Processes
Some antibiotics can interfere with various metabolic pro-
cesses that are vital to the survival of bacteria. Folate and folic 
acid are essential for the synthesis of purines, thymidines, and 
some amino acids (Lange, et.al. 2007). The folic acid pathway 
is catalyzed by dihydropteroate synthetase and dihydrofolate 
reductase, two enzymes which aid in the production of 7, 8 
dihydropteroate and tetrahydrofolate, respectively (Shledon Jr., 
2005). Drugs like sulphonamide and trimethoprim block dif-
ferent steps in this folic acid pathway, and while sulphonamide 
competitively binds to p-aminobenozic acid in order to prevent 
the actions of dihydropteroate synthetase, trimethoprim binds 
to the enzyme dihydrofolate reductase to prevent the reduction 
of dihydrofolic acid to tetrahydrofolic acid (Bockstael, Aerschot, 
2009) (Sheldon Jr., 2005). 
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5. Inhibition of DNA Replication
Topoisomerases I, II, III, and IV are enzymes that are essential 
for DNA replication in bacterial species (Walsh, 2000). Bacterial 
DNA is negatively supercoiled, and during DNA replication, 
topoisomerase II, DNA gyrase, removes positive supercoils, 
breaks the double bond, and decreases the linking number by 
two. Furthermore, during DNA replication, topoisomerase IV 
unlinks the daughter chromosomes (Bockstael, Aerschot, 2009). 
Topoisomerases II and IV are vital for DNA topology, replica-
tion, and decatenation, and quinolone antibiotics target these 
enzymes. By interacting with the complex formed between DNA 
and DNA gyrase, quinolones make conformational changes that 
affect the activity of both topoisomerases II and IV, and as a result, 
DNA replication is blocked (Bockstael, Aerschot, 2009).
The process of transcription, the transferring of genes from 
DNA to mRNA, is mediated by the multi-subunit enzyme RNA 
polymerase. The antibiotic rifamycin targets DNA transcription 
by binding to the beta subunit of RNA polymerase. Rifamycin 
??????? ????????????? ????????????????????? ????????????????? ????
action of RNA polymerase and inhibiting mRNA synthesis 
(Bockstael, Aerschot, 2009). 
B. Mechanism of Resistance
??????????? ???? ??? ?????????? ??? ??????? ?????????? ??? ???????????
?????????? ??????????? ??? ??????????? ????? ??? ????????? ??? ?? ????????
species of bacteria. For example, the bacteria belonging to the 
genus of Enterobacter, Klebsiella, and Escherichia coli are all re-
sistant to methicillin, clindamycin, and vancomycin (James, 1999). 
Various species of bacteria all differ in the variation of their 
?????????????????????????????????? ????????????????????????????????
different bacteria’s innate resistance to certain drugs (Sheldon 
Jr., 2005).  
Extrinsic or acquired resistance, on the other hand, arises 
when bacteria acquire new resistance to numerous drugs via 
different mechanisms. Resistant bacteria can degrade and modify 
enzymes, alter the targets of antibiotics, change the permeability 
of their cell wall, or alter metabolic pathways to prevent drugs 
from penetrating and affecting their cells (Sheldon Jr., 2005). 
1. Enzymatic Degradation or Alteration
Some bacterial species can resist a wide array of drugs by enzy-
matic degradation and alteration. By producing an enzyme that 
destroys an antibiotic, bacterial species can cause various antibi-
otics to become ineffective. Antibiotics like penicillins, carbapen-
ems, and cephalosporins all contain a B-lactam ring which binds 
to PBPs on the peptidoglycan to prevent cross linkage of the 
cell wall (James, 1999). In response, various bacteria produce 
different classes of B-lactamases to hydrolyze the four mem-
bered B-lactam rings and thereby inactivate these antibiotics 
(Sibanda, Okoh, 2007). 
Similar to the B-lactamases, the aminoglycoside modifying 
enzymes (AMEs) are enzymes that cause bacterial resistance to 
aminoglycosides. Some microorganisms can produce enzymes 
that modify drugs. Aminoglycosides like kanamycin, gentamicin, 
streptomycin, and neomycin can either be acylated, adenylated, 
or phosphorylated by aminoglycoside acetyltransferase, adenyl-
transferase, and phosphoryltransferase. Consequently, the mod-
???????????????????????? ????????????? ????????????????????????????
(James, 1999) (Gabani, et. al 2012). 
2. Alteration of Targets
 In order to have a combative effect on bacteria, antibiotics must 
bind to their intended receptors. Therefore, in response to vari-
????????????????????????????????????????????????????????????????????
by modifying the structure of the drugs’ active site. Different bac-
terial species like methicillin-resistant Staphylococcus aureus and 
Streptococcus pneumoniae produce new penicillin binding pro-
teins, PBP2a and PBP2b respectively, in the presence of antibiotics. 
????????????????????? ??????????? ?? ?????? ???????? ??????????????
which, in turn, prevent the drugs from properly binding and having 
an antibacterial effect (James, 1999). Furthermore, substituting at 
?????????????????????????????????????????????????????????????????????
drug, and as a result the bacterial cell wall is not destroyed by the 
antibiotic (Gabani, et. al. 2012) (Sibanda, Okoh, 2007).
In different species of bacteria, the N^6 amino group of an adenine 
residue located in 23S rRNA is methylated, and as a result bac-
terial resistance to macrolides, lincosamides, and streptogramin 
B arises. The mechanism behind this resistance is associated with 
??????????????????????? ???????????? ?????? ????? ???????? ????????-
formational changes from the methylation (Sibanda, Okoh, 2007). 
3. Alteration of Permeability
In addition to altering the targets of antibiotics, drug resistant 
bacteria can modify the permeability of their cell wall in order 
to prevent or decrease the entrance of various drugs into the 
cell. A drug’s concentration in the bacterial cell determines the 
???????? ??? ???? ????? ??? ???? ?????????? ???? ??? ??? ???????? ?????
?????????????????????????????????????????????????????????????
ability to decrease the amount of drug that reaches the cell 
(Lange, et.al. 2007) (James, 1999) (Sheldon Jr., 2005).
?????????? ?????????????????????????????????????????? ???????????????
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Porins
Porins are protein channels that exist solely in the outer mem-
branes of gram negative bacteria.  These channels are highly 
???????????????????????????????????????????????????????????????-
cules can pass through to the inside of the cell. Being hydrophilic 
molecules, antibiotics easily enter the cell through these protein 
channels. Research has shown that when bacteria lose porins in 
their outer membrane, drug resistance emerges since less of the 
antibiotic can enter into the cell. For example, when the amount 
of OPrD porins were decreased in Pseudomonas, the imipenem 
class of antibiotics could not enter the bacterial cell. Similarly, 
resistance to imipenem and meropenem occurred after the 
amount of 29-kDa Porins was reduced in Acinetobacter bau-
mannii. Multi-drug resistant bacteria like Klebsiella pneumoni-
ae also display resistance to cephalosporins and carbapenems 
after losing OmpK35 and OmpK36, outer membrane proteins 
(Santajit, Indrawattana, 2016). 
???????????
?????? ?????? ????????? ?????????? ?????? ???? ??? ???? ?????????? ?????
thereby decreasing the intracellular concentration of different 
??????????????????? ???? ???? ?????????? ??????????? ??? ?????? ??????
that exist in either gram positive or gram negative bacteria. The 
ABC, RND, MFS, SMR, and Multidrug and toxic compound ex-
???????? ??????? ????????????????????????????????? ??? ????????? ???
the phospholipid bilayer, and thereafter export it out of the cell 
to different locations. While gram positive bacteria transporters 
work by pumping the drug out of the cell across the cytoplasmic 
???????????????????????????????????????????????????????????
antibiotic across the membrane and into the periplasmic space, or 
??????????????????????????????????? ????????????????????????????
extrude the antibiotics out, the concentration of antibiotics can-
not accumulate to a high enough level to have an antibacterial 
effect (Zgurskaya, 2002) (Lomovskaya, Watkins, 2001).
4. Altered Metabolic Pathway
Resistant bacteria have come up with alternate routes to obtain 
metabolic products that are blocked by antibiotics. The folic acid 
pathway produces pyridine thymidylate, an essential molecule in 
the synthesis of DNA.  In order to circumvent antibiotics that 
target the folate pathway, Enterococcus either uses folinic acid 
from its host cell, or mutates to have the ability to produce 
thymine (Mambrio-Jones, Hoek, 2010) (Sheldon Jr., 2005).
Discussion: 
C. Combating Drug Resistance
According to statistics, it is predicted that an estimated 10 
million people will die from drug-resistant bacterial infections 
by 2050 if no viable solution is discovered (Press Association, 
??????? ?????????????????????????????????????????????????????????
bacteria is of extreme importance.  Over the last few years, 
much research has been done to determine proper treatments 
for such deadly infections. This paper will discuss the effective-
ness of silver nanoparticles against drug resistant bacteria. 
1. Silver Nanoparticles
Silver is widely known for its antimicrobial properties, and 
therefore, silver nanoparticles (Ag NPs) have been widely 
studied as a potential antibacterial agent against drug-resistant 
bacteria. Various studies on different strains of bacteria were 
performed to uncover the antibacterial effects of Ag NPs. More 
?????????????????????????????????????????????????????????????????
these silver particles coupled with the potential toxicity they 
pose to human cells. 
There are various methods to create nanoparticles. Ag NPs 
can be synthesized into different shapes and sizes via physical 
processes like laser ablation, evaporation, and condensation, or 
through chemical processes like hydrazine, sodium borohydride, 
and green synthesis (Nurani, et.al. 2015). 
1. Mode of Action of Silver Nanoparticles
After determining the bactericidal properties of silver nanopar-
ticles, the mechanism behind their antimicrobial effects was 
studied. Various studies using transmission electron microscopy 
???????????????? ???????????????????? ?? ???????????????????????
cause damage to bacterial cells through a wide array of different 
mechanisms. 
A Kirby-Bauer sensitivity test was performed, and by using var-
ious antibiotic discs with different silver resistant bacterial strains, 
the zone of inhibition was measured. It was found that the bac-
????????????? ?????????????????????????????????????????????????-
??????? ????????????????? ???? ????????????????? ???????? ???????????
the mechanism of action of Ag NPs. Based on the action of these 
antibiotics and the bacteria’s altered zone of inhibitions, this study 
showed that these particles interact with the cell wall, proteins, 
and DNA (Lara et. al. 2010). 
Because of their small size, silver nanoparticles have the ability 
to attach to the surface of the cell membrane and disrupt its 
function. The positive charge of the Ag NPs allows them to elec-
trostatically interact with the negatively charged membrane (Lara, 
et.al. 2011). As transmission electron microscopy has shown with 
E. coli cell membranes, silver nanoparticles disrupt the cell mem-
brane, increase the cell’s permeability, and ultimately cause cell 
death (Dakal, et. al. 2016) (Mambrio-Jones, Hoek, 2010). 
?????????????????????????????????????????????????????????????-
rus (Nurani, et.al. 2015). Therefore, Ag NPs can also adsorb to 
the cell membrane by interacting with thiol (SH) groups on the 
cell membrane. As a result of this interaction, a new bond be-
tween sulfur and silver (S-Ag) is formed, and the creation of 
this new bond blocks both respiration and the electron trans-
fer. Ultimately, this results in the collapse of the proton motive 
force. Without the proton motive force, the cell membrane 
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is disrupted and cell leakage followed by cell death ensues 
(Mijnendonckx, et. al. 2013). 
Moreover, after weakening the cell membrane, these parti-
cles have the ability to penetrate the bacteria (Lara, et.al. 2010) 
(Mijnendonckx, et.al. 2013). Additionally, in gram negative bacte-
ria, porins help facilitate the entry of Ag NPs into the cell. Once 
inside, these Ag NPs interact with various molecules resulting in 
further cell damage (Dakal, et. al. 2016). 
??????? ????? ?? ??????????? ??????? ??????? ????????????? ???????
particles interact with thiol groups resulting in conformational 
changes that ultimately inhibit the activity of various enzymes 
(Mijnendonckx, et.al. 2013).  Furthermore, when silver particles 
bind to the guanine base, pyrimidine dimerization occurs, and 
DNA replication is inhibited. Silver particles can also affect pro-
tein production and translation by interacting with and subse-
quently denaturing ribosomes (Dakal, et.al. 2016). 
Moreover, silver nanoparticles are oxidized into silver ions 
upon entering the bacterial cell. Ag ions cause damage and cell 
death by interacting with lipids, proteins, and DNA. Silver ions 
also interact with nucleosides in addition to forming complexes 
with nucleic acids. Furthermore, these ions bind and dimerize 
DNA and RNA, block the expression of proteins and enzymes 
involved in ATP production, and generate free radicals (Lara, 
et.al. 2010) (Mijnendonckx, et.al. 2013). 
Reactive oxygen species can be endogenously produced from nat-
ural metabolic processes like aerobic respiration. Metal ions, like 
silver, have the ability to catalyze the generation of free radicals 
in the presence of oxygen (Mambrio-Jones,Hoek, 2010), and spin 
resonance measurements have shown that silver ions increase 
the production of reactive oxygen species (Mijnendonckx, et.al. 
2013) (Mambrio-Jones, Hoek, 2010) (Kim, et. al. 2007). These free 
radicals then act upon the mitochondrial membranes to induce 
necrosis and cell death. Furthermore, ROS oxidize lipids, nucleic 
acids, and proteins, thus disrupting the level of homeostasis by 
inducing oxidative stress and cell damage. 
In addition to increasing the production of ROS, silver particles 
also decrease the levels of glutathione, an antioxidant, by reducing 
??? ????? ???????????? ???????????????????????? ???????? ???? ??????????
??????????????????????????????????????????????????????????????
and superoxide dismutase, anti-oxidative enzymes that quench free 
radicals. These enzymes are dependent on thiol groups, but since 
silver ions interact with thiol groups, these enzymes cannot prop-
erly quench the reactive oxygen species (Mijnendonckx, et.al. 2013) 
(Dakal, et.al. 2016).  
Phosphorylation and dephosphorylation are important signaling 
processes in bacterial growth. Phosphorylated proteins guide DNA 
replication and recombination, metabolism, and bacterial cell cycle. 
Silver nanoparticles block this signaling pathway to prevent the 
production and action of phosphorylated proteins. Furthermore, 
phosphorylated tyrosine kinases aid in the transport of exopoly-
saccharide and capsular polysaccharides. Therefore, to prevent 
bacterial growth, Ag NPs can also dephosphorylate these tyrosine 
residues (Dakal, et. al. 2016) (Shirvastava, et.al. 2007).
Effects of Silver Nanoparticles on Gram Positive 
and Gram Negative Bacteria
???????????????????????????????????????????????????????????????????
nanoparticles in both gram negative and gram positive bacteria. 
In some studies, the Ag NPs had an equal effect in both types of 
bacteria, rendering silver as a potential broad antibacterial agent 
(Lara, et. al. 2010). However, other studies found that these par-
ticles are more effective in gram negative bacteria. This phenom-
enon is attributed to the differences in the composition of the 
cell wall in both gram positive and gram negative bacteria. The 
peptidoglycan in gram positive bacteria is very thick, averaging 
around 20-80 nm, and rigidly cross linked. Because of this thick, 
rigid membrane, there are fewer sites for the silver to adhere to, 
making it harder for the particles to adsorb and penetrate the 
cell. On the other hand, the cell wall of gram negative bacteria is 
composed of a much thinner, roughly 7-8 nm, and weaker PG. In 
addition, the membrane of gram negative bacteria contains the 
lipopolysaccharide (LPS). Because of its negative charge, the LPS 
increases the silver nanoparticles’ ability to successfully bind to 
the cell’s surface. The thinner and weaker PG coupled with the 
negatively charged LPS makes gram negative bacteria more sus-
ceptible to silver nanoparticles (Feng, et.al. 2000) (Shirvastava, 
et.al. 2007) (Dakal. et.al. 2016). 
2. Size of  Silver Nanoparticles
?????????????????????????????????????????????????????????????????
toxicity of silver particles. Extensive research has been done in 
attempt to uncover the antibacterial effects of different sized 
Ag NPs. Using the disk diffusion method, one study compared 
???????????????????????????????????????????????????????????????
positive and gram negative bacteria. The relationship between 
???????????????????? ?? ????????????????????????????????????????
it was concluded that the two are inversely related; the small-
er the diameter of the particle, the more effective it is against 
??????????????? ?????????????? ???????? ??? ???????? ??????????????
compared to larger NPs can be attributed to the relationship 
between surface area and size. Surface area and particle size is 
inversely related; the smaller the particles are, the larger their 
surface area is (Rai, et. al. 2014). As a result of the increased 
surface area, the smaller particles can interact with the bacterial 
??????????????????????????????????????????????????????????????
3. Dose of Silver Nanoparticles
After determining the mode of action of Ag NPs, researchers 
began to study the dose required to have a bactericidal effect. By 
using various doses, 0.0, 6.25, 12.5, 25.0, and 50.0 mM, against dif-
ferent strains of bacteria, it was found that dose and antibacterial 
effect were directly related; the higher the dose of the Ag NPs, 
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the more effective they were. The highest dose, 50.0 mM, was the 
most successful at killing bacteria (Lara, et.al. 2010). Furthermore, 
the dose required to have a combative effect was found to be 
?????????????????????????????????????????????????????????
4. Shape of  Silver Nanoparticles
In addition to amount and size, shape also plays a role in the 
?????????????????????????????????????????????????????????????????????
??????? ???? ???? ????????? ????? ???? ???????? ??? ?????????? ????????
Because of their large densities, facets have a higher surface 
reactivity, and therefore Ag NPs with more {111} facets, facets 
that are cut through the x, y, and z planes, have a greater effect 
against bacteria (Mambrio-Jones, Hoek, 2010). Some research has 
shown that triangular shaped particles are more effective than 
both sphere and rod shaped particles at combating drug resistant 
bacteria.  The increased surface area and antibacterial effect of 
triangle shaped particles can be due to their geometric structure 
which contains numerous facets (Mambrio-Jones, Hoek, 2010) 
(Raza, et.al. 2016) (Pal, et.al. 2007) (Mijnendonckx, et.al. 2013).
However, other research found contradictory results. Using 
the disk diffusion method, the zone of inhibition of Pseudomonas 
????????????????????????????? ???? ??????? ???? ?????????? ??????
and shaped particles: S1, S2, S3, S4, and S5, was measured. While 
S1, S2, S3, S5 were all sphere shaped varying in size, S4 was 
triangular shaped. After placing the particles in the center of 
the sampled bacteria on an agar plate, the zone of inhibition of 
S2, the smallest sphere particle, was 1.5 mm, while the zone of 
inhibition for the triangular shaped particles was 1.4 mm. This 
demonstrated that the smallest sphere particle had a greater 
effect than the triangular shaped one (Raza, et.al. 2016).  Using 
x-ray diffraction, it was determined that the smaller spherical 
shaped particles also contained high atomic density facets that 
are found in triangular shaped Ag NPs which evidently contrib-
uted to the sphere’s greater bactericidal effect. Furthermore, 
the sphere shaped Ag NPs acted as acids and interacted with 
bases, sulfur and phosphorus containing compounds, to cause 
damage to both the cell membrane and DNA (Raza, et.al. 2016). 
5. Toxicity of Silver Nanoparticles
The toxicity of any antimicrobial agent is a major issue of con-
cern, and despite silver particles’ potential to act as an antimi-
crobial agent, at certain levels, silver nanoparticles can be toxic 
to all mammals, including humans.  Research has shown that Ag 
NPs stimulate an immune response and induce apoptosis via the 
JNK and ROS signaling pathways. As indicated by the levels of 
glutathione, silver particles induce oxidative stress by decreas-
ing the amount of the glutathione in the body. Additionally, due 
to their high surface area, Ag NPs can also generate free radicals 
from the respiratory chain. This imbalance between ROS and 
antioxidant levels results in damage to both lipids and proteins 
(Arora et.al. 2008) (Mambrio-Jones, Hoek, 2010). Silver NPs 
also interact with the mitochondria to increase oxidative stress 
and to disrupt ATP production, ultimately causing damage to 
DNA. Ag NPs also affects protein folding. This increased stress 
in the cell leads to cytotoxicity and apoptosis. Furthermore, Ag 
NPs can enter the nucleus and induce genotoxicity by causing 
DNA mutations, base damages, and strand breaks. Finally, these 
particles induce carcinogenesis by activating different signaling 
????????????????????????????????????????????????????????
In a few studies, it was found that the dose of Ag NPs needed 
to induce apoptosis was different from the dose required to stim-
ulate necrosis, 0.78-1.56 vs. 12.5 μg. Therefore, it was concluded 
that a safe dosing range of silver can be determined (Mambrio-
Jones, Hoek, 2010). However, a contradictory conclusion was 
reached by AshaRani et. al who found silver nanoparticles can be 
toxic to humans at any dose (AshaRani et.al. 2009) (Mambrio-
Jones, Hoek, 2010).  Therefore, due to this discrepancy, further 
research in regards to the toxicity of Ag NPs must be conducted.
?????????
????????????????????
1. ?????????????????????????????
2. Adsorption to cell surface
3. Penetration into the cell to cause damage to various biomolecules
4. Generate ROS
5. Affect signaling processes
?????????
??????????????????????
????????????????
?????????????????????????????????????????????
????????????????????????????????
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6. Resistance to Silver Nanoparticles
As is the case with antibiotics, bacterial resistance to silver is a 
major concern. When bacteria are exposed to silver nanopar-
ticles, it results in the natural selection of bacteria, thus causing 
bacterial resistance to silver particles.  
Bacterial resistance to silver NPs can be encoded in the plas-
mid or in the chromosome as it is seen in both Salmonella and E. 
coli respectively (Mambrio-Jones, Hoek, 2010). In Salmonella, the 
resistance to silver ions is attributed to nine genes on the plasmid. 
Furthermore, resistance is also associated with the SilCBA and 
??????????????????????????????????????????????????????????????????
and in Escherichia coli porin loss. However, resistance to silver 
nanoparticles as a result of a one point mutation is not very com-
mon because of the complexity of silver’s actions (Chopra, 2007).
Additionally, since silver nanoparticles have a high surface area, 
they can aggregate and combine together, causing them to lose 
their antibacterial effect (Nurani, et.al. 2015) (Beyth, et.al. 2015). 
Furthermore, because of its high surface energy, Ag NPs can be-
come contaminated by the air, and therefore Ag NPs are syn-
thesized with either chitosan, alginate, or gelatin, biodegradable 
polymer matrixes, to prevent their oxidation (Nurani, et.al. 2015). 
7. Combination of antibiotics and AG NPs
The synergy of two drugs or compounds has the potential to 
successfully combat drug-resistant bacteria by acting through 
different mechanisms. Therefore, after determining the bacteri-
cidal effect of silver nanoparticles, many researchers attempted 
to determine the effects of the use of Ag NPs in conjunction 
with the use of antibiotics against different strains of bacteria. 
To determine the synergy of Ag NPs with drugs, silver particles 
were used with amoxicillin against samples of E. coli. By com-
paring the minimum inhibitory concentration of various doses 
of silver nanoparticles alone, the use of different amounts of 
amoxicillin by itself, in addition to the combined effects of both 
silver NPs and amoxicillin, the advantages of combination ther-
????????????????????
The combined effect of amoxicillin and Ag NPs was seen 
to have a greater bactericidal effect than each of them alone. 
Furthermore, when the two were administered together, a lower 
dose of both amoxicillin and silver nanoparticles were needed to 
stimulate an antibacterial effect as opposed to when each one 
was given alone (Allahverdiyev, et. al. 2011) (Li, et. al 2005). 
The success for this synergy can be attributed to a few differ-
ent theories. With combination therapy, the two compounds or 
drugs that are used usually target different steps, pathways, or 
enzymes. Therefore, if bacteria resist the action of one antibiot-
ic, the other compound can still exert its antimicrobial effects 
through a different non-resistant mechanism.
Additionally, in non-resistant bacteria, the synergy of the two 
can be attributed to the chelation reaction that occurs between 
both the hydroxy and amino groups of the B-lactam and the Ag 
NPs. The binding between the silver and the amoxicillin in addi-
tion to the binding between the antibiotic with other drug par-
ticles resulted in the formation of a new compound. This newly 
synthesized antimicrobial agent, containing silver on the inside 
and amoxicillin on the outside, attaches to the surface of the cell 
membrane and causes more damage because of the synergy of 
the two compounds. Additionally, the amoxicillin disrupted the 
cell wall which increased the penetration of the Ag NPs into the 
cell.  Moreover, from this chelation reaction, silver nanoparticles 
prevent DNA from unwinding, thus resulting in further damage 
to bacterial DNA (Li, et. al. 2005) (Allahverdiyev, et. al. 2011).
Furthermore, silver nanoparticles can be used as a drug carri-
er. While antibiotics are usually hydrophilic, silver nanoparticles 
are hydrophobic. Therefore, these nanoparticles can interact 
with the hydrophobic bacterial cell membrane more easily than 
antibiotics, enabling the transport of hydrophilic antibiotics to 
the bacterial cell surface (Li, et. al. 2005). 
Conclusions
This paper attempted to explain the mechanism of action and 
mechanism of resistance of antibiotics and drug resistant bacte-
ria, respectively. As antibiotic resistance continues to emerge, re-
searchers are constantly searching for new antimicrobial agents. 
Silver nanoparticles have gained much attention as a possible 
tool in combating drug resistant bacteria, and studies have prov-
?????????????????? ????????????????????????????????????????????
However, despite the growing potential of silver nanoparticles, 
????????
??????????????????
The formation of a new antimicrobial agent through the chelation 
?????????????????????????????????????????????????????
????????
?????????????????????????????
The mechanism of action of the combination of B-lactam antibiotics 
????????????????????????????????????? ??????????????????????????????
??????????????????????????????????????????????????????????? ??????????
????????????????????????????????
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further research must be conducted before implementing silver 
nanoparticles into clinical trials as a promising way of replacing 
or supplementing the currently used antibiotics. 
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